| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/2010 | US20100113300 T cell receptor display |
| 05/06/2010 | US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
| 05/06/2010 | US20100112593 Method of Predicting the Clinical Response to Chemotherapeutic Treatment with Alkylating Agents |
| 05/06/2010 | US20100112591 Tumor Suppressor Gene |
| 05/06/2010 | US20100112099 Phytochemical compositions and methods for activating amp-kinase |
| 05/06/2010 | US20100112091 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 05/06/2010 | US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 05/06/2010 | US20100112089 Peptide compound and use thereof |
| 05/06/2010 | US20100112080 MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN |
| 05/06/2010 | US20100112079 Thyroid Hormone Analogs and Methods of Use |
| 05/06/2010 | US20100112070 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 05/06/2010 | US20100112067 Compositions and methods for biological remodeling with frozen particle compositions |
| 05/06/2010 | US20100112057 Multifunctional and biologically active matrices from multicomponent polymeric solutions |
| 05/06/2010 | US20100112044 Method and apparatus for encapsulating pharmaceutical and nutriceutical bioactives for intestinal delivery |
| 05/06/2010 | US20100112042 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 05/06/2010 | US20100112038 Methods of treating neurological conditions with hematopoeitic growth factors |
| 05/06/2010 | US20100112030 Role of hedgehog signaling in atherosclerosis and cardiovascular disease |
| 05/06/2010 | US20100112028 Composite material for use as protein carrier |
| 05/06/2010 | US20100112027 Penis Enlargement |
| 05/06/2010 | US20100112014 Novel hydrogel compositions and methods of using |
| 05/06/2010 | US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 05/06/2010 | US20100111988 Small peptide for anti-angiogenesis and use thereof |
| 05/06/2010 | US20100111978 Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure |
| 05/06/2010 | US20100111977 Methods and compositions for treatment of myotonic dystrophy |
| 05/06/2010 | US20100111968 Methods for Mediating Fibrotic Response |
| 05/06/2010 | US20100111964 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/06/2010 | US20100111952 Treatment of autoimmune disorders |
| 05/06/2010 | US20100111943 Compositions and methods for inhibiting cancer metastasis |
| 05/06/2010 | US20100111942 Combination therapy for the treatment of ocular neovascular disorders |
| 05/06/2010 | US20100111941 Methods for treating cancer |
| 05/06/2010 | US20100111940 Compositions containing alpha-1-antitrypsin and methods for use |
| 05/06/2010 | US20100111937 Modulation of Toll-Like Receptor 5 Expression by Antisense Oligonucleotides |
| 05/06/2010 | US20100111933 Acid soluble proteins from micellar casein |
| 05/06/2010 | US20100111929 Method of treating peripheral nerve disorders |
| 05/06/2010 | US20100111926 Method of Using Salmon Thrombin to Alleviate Central Nervous System-Mediated Pain |
| 05/06/2010 | US20100111925 Compositions of Engineered Human Arginases and Methods for Treating Cancer |
| 05/06/2010 | US20100111924 Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site |
| 05/06/2010 | US20100111923 Use of alkaline phosphatase in the treatment of reduced renal function |
| 05/06/2010 | US20100111922 Animal model and use of 17beta-hydroxysteroid dehydrogenase type 7 in the diagnosis of anencephaly |
| 05/06/2010 | US20100111921 Use of IL-1 Antagonists to Treat Gout |
| 05/06/2010 | US20100111920 Methods and compositions for the treatment of vaginal diseases employing peroxide-producing enzymes and peroxidases |
| 05/06/2010 | US20100111919 Delayed gelation compositions and methods of use |
| 05/06/2010 | US20100111918 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| 05/06/2010 | US20100111917 Cell-adhesive polyelectrolyte material for use as membrane and coating |
| 05/06/2010 | US20100111907 Methods and compositions for gene inactivation |
| 05/06/2010 | US20100111903 Compositions produced using enteric pathogens and methods of use |
| 05/06/2010 | US20100111902 Composition for transmucosal delivery of polypeptides |
| 05/06/2010 | US20100111901 Triazole inhibitors of aromatase |
| 05/06/2010 | US20100111900 Heterocyclic antiviral compounds |
| 05/06/2010 | US20100111899 Materials and Methods for Immunizing Against FIV Infection |
| 05/06/2010 | US20100111898 Conjoint therapy for treating fibrotic diseases |
| 05/06/2010 | US20100111897 Methods and Compositions Useful for Diabetic Wound Healing |
| 05/06/2010 | US20100111895 Human sample matching system |
| 05/06/2010 | US20100111894 Metap-2 inhibitor polymersomes for therapeutic administration |
| 05/06/2010 | US20100111874 Method of cancer detection and treatment |
| 05/06/2010 | US20100111866 Receptor and Antigen Targeted Prodrug |
| 05/06/2010 | US20100111865 Contrast agents |
| 05/06/2010 | US20100111855 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111853 Antibodies that bind to il-12 and methods of purifying the same |
| 05/06/2010 | US20100111845 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111842 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111838 Brain-localizing polypeptides comprising a multivalent binding moiety and improved metabolic stability |
| 05/06/2010 | US20100111837 Compositions and methods for biological remodeling with frozen particle compositions |
| 05/06/2010 | US20100111832 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | DE102009035593A1 N-terminal modifizierte Tetrapeptidderivate mit C-terminalem Argininmetikum N-terminally modified tetrapeptide derivatives with C-terminal Argininmetikum |
| 05/06/2010 | CA2751766A1 Cyclic depsipeptide compound and use thereof |
| 05/06/2010 | CA2742497A1 Compositions of engineered human arginases and methods for treating cancer |
| 05/06/2010 | CA2742064A1 Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor |
| 05/06/2010 | CA2741798A1 Anti-muc1 antibody |
| 05/06/2010 | CA2741426A1 Method and device for activating stem cells |
| 05/06/2010 | CA2740058A1 An antidiabetic agent |
| 05/06/2010 | CA2739712A1 Peptide having anti-diabetic activity and use thereof |
| 05/06/2010 | CA2739705A1 Efficient expression of truncated human rnaset2 in e. coli |
| 05/06/2010 | CA2738615A1 Treating diabetes melitus using insulin injections with less than daily injection frequency |
| 05/05/2010 | EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 05/05/2010 | EP2182064A1 Gene expressed in prostate cancer |
| 05/05/2010 | EP2182063A2 Modulation of EIF4E expression |
| 05/05/2010 | EP2182059A1 Rapidly degraded reporter fusion proteins |
| 05/05/2010 | EP2182006A2 Compositions and methods for the treatment of immune related diseases |
| 05/05/2010 | EP2182005A1 A gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 05/05/2010 | EP2182004A1 Combination therapy of isotopically labelled chlorotoxin with temozolomide |
| 05/05/2010 | EP2182003A1 Peptide capable of binding to immunoglobulin |
| 05/05/2010 | EP2181731A1 Organic compounds with biological effect as thrombin inhibitor and use of same |
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181713A1 Pharmaceutical compositions for prevention or treatment of Lewis Y antigen related diseases and kits for detecting Lewis Y antigen |
| 05/05/2010 | EP2181712A1 Use of glucagon-like peptide-1 or analogs to abolish catabolic changes after surgery |
| 05/05/2010 | EP2181595A1 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 05/05/2010 | EP2181101A2 Tubulysin d analogues |
| 05/05/2010 | EP2180899A2 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases |
| 05/05/2010 | EP2180898A2 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
| 05/05/2010 | EP2180897A1 Peptide tyrosinase inhibitors and uses thereof |
| 05/05/2010 | EP2180881A2 Vesicles comprising a transmembrane transport trigger system |
| 05/05/2010 | EP1989304B1 A method of removing a non-metallic protein inhibitor from a liquid pharmaceutical preparation |
| 05/05/2010 | EP1790655B1 Biologically active peptides |
| 05/05/2010 | EP1734987B1 Interferon-beta for anti-virus therapy for respiratory diseases |
| 05/05/2010 | EP1730198B1 Adzymes and uses thereof |
| 05/05/2010 | EP1648520B1 Compounds and methods for downregulating the effects of tgf-beta |
| 05/05/2010 | EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 05/05/2010 | EP1567545B1 Peptides and their use in the treatment of central nervous system damage |
| 05/05/2010 | EP1427817B1 Multiplication of viruses in a cell culture |